agglomeransstrains that were negative

forpaaABC(i.e., with no genomic island insertion). The large size of the genomic island inpaaABC-positive strains prevented recovery of a PCR-product amplicon. This indicates that the insertion site of the pantocin genomic island is the same as in C9-1 for allPantoeastrains Selleck GDC 0449 carrying the pantocin A genes. The origin of the pantocin genes remains unknown, and no near or distant homologues have been identified in any other organism after an extensive BLAST search. The T3SS genehrcNwas identified PFT�� in several isolates (Figure7), including the two phytopathogenicP. agglomeranspv.gypsophilaestrains (i.e., ATCC 43348 and CFBP 4342) for which a T3SS has been previously reported [44,45]. Whether this suggests that these strains may have some T3SS components and thus have pathogenic potential (e.g., on plants) remains uncertain. Strains which amplifiedhrcNincluded Selleckchem Ricolinostat four environmental strains

(CIP 82.100, LMG 2557, P3SAA, P7NSW), one clinical strain (VA21971) and two biocontrol isolates (CPA-2, Eh239). Subsequent sequencing of the obtained fragment revealed that thehrcNgene in all of these strains diverged significantly from thehrcNsequence carried byP. agglomeranspv.gypsophilaeand other plant pathogenic bacteria. The sequence they carried was more closely related to that ofPseudomonas fluorescensstrains used in biocontrol of soilborne plant diseases (Figure7), indicating a non-pathogenic alternative function. Figure 7 Phylogeny of P. agglomerans sensu stricto strains of diverse origin based on partial sequencing the hrcN gene, coding for the type III secretion system-specific ATPase. A total of 32P. agglomeransor nearly related strains (e.g., SC-1 or LMG 5343) were tested for the presence of a T3SS using primers hrcN-4r and hrcN-5rR, which were designed on the basis of the alignment of thehrcNgenes

ofE. amylovoraandPseudomonas syringae. A positive amplification was obtained Cisplatin order as expected in two known plant pathogens (P. agglomeranspv.gypsophilaeCFBP 4342 andP. agglomeranspv.gypsophilaeATCC 43348) and in seven more strains, including four environmental strains (CIP 82.100, LMG 2557, P3SAA and P7NSW), one clinical isolate (VA21971) and two biocontrol strains (Eh239 and CPA-2). Sequence analysis revealed that thehrcNgene found in the latter seven strains is more similar to that of biocontrolP. fluorescensand is not closely related toP. agglomeranspv.gypsophilaeor other plant pathogenic bacteria, indicating a divergent function. GenBank accession numbers of reference sequences not obtained in this work are indicated between square brackets. Discussion Discrimination of clinical and plant-associated isolates ofP. agglomeranshas important implications for the registration of biocontrol products for plant protection.